Spire Healthcare Group (LON:SPI) Stock Price Up 14.1% - Here's Why

Key Points

• Spire Healthcare Group's stock price surged 14.1% during mid-day trading, reaching a high of GBX 256.50 ($3.46) and seeing trading volume increase by 563% from its average.
• Research analysts are generally optimistic, with three firms rating the stock as a Buy and a consensus price target of GBX 294.33.
• For the most recent quarter, Spire reported earnings per share of GBX 4.10 and is projected to reach approximately 15.66 earnings per share for the current fiscal year.

Shares of Spire Healthcare Group plc (LON:SPI - Get Free Report) shot up 14.1% during trading on Saturday . The company traded as high as GBX 256.50 ($3.47) and last traded at GBX 247 ($3.34). 9,747,062 shares changed hands during mid-day trading, an increase of 563% from the average session volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.93).

Analyst Upgrades and Downgrades

SPI has been the subject of several recent research reports. Berenberg Bank reissued a "buy" rating and set a GBX 280 price objective on shares of Spire Healthcare Group in a report on Thursday, July 31st. JPMorgan Chase & Co. cut their price objective on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a report on Tuesday, August 5th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has an average rating of "Buy" and an average price target of GBX 294.33.

Spire Healthcare Group Trading Down 4.7%

The business has a 50 day simple moving average of GBX 218.99 and a 200-day simple moving average of GBX 203.96. The stock has a market capitalization of £947.58 million, a price-to-earnings ratio of 5,119.57, a PEG ratio of 1.06 and a beta of 0.96. The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74.

Spire Healthcare Group (LON:SPI - Get Free Report) last announced its earnings results on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. As a group, equities analysts expect that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.